Organ transplantation - how much of the promise has been realized?

被引:292
作者
Lechler, RI
Sykes, M
Thomson, AW
Turka, LA
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Kings Coll London, Guys Kings & St Thomass Med Sch, London SE1 9RT, England
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02129 USA
[4] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02129 USA
[5] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA
[6] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA
关键词
D O I
10.1038/nm1251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since the introduction of organ transplantation into medical practice, progress and optimism have been abundant. Improvements in immunosuppressive drugs and ancillary care have led to outstanding short-term ( 1 - 3-year) patient and graft survival rates. This success is mitigated by several problems, including poor long-term (> 5-year) graft survival rates, the need for continual immunosuppressive medication and the discrepancy between the demand for organs and the supply. Developing methods to induce transplant tolerance, as a means to improve graft outcomes and eliminate the requirement for immunosuppression, and expanding the pool of organs for transplantation are the major challenges of the field.
引用
收藏
页码:605 / 613
页数:9
相关论文
共 90 条
[1]   CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris [J].
Abrams, JR ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Goldfarb, MT ;
Goffe, BS ;
Menter, A ;
Lowe, NJ ;
Krueger, G ;
Brown, MJ ;
Weiner, RS ;
Birkhofer, MJ ;
Warner, GL ;
Berry, KK ;
Linsley, PS ;
Krueger, JG ;
Ochs, HD ;
Kelley, SL ;
Kang, SW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1243-1252
[2]   Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9 [J].
Armstrong, N ;
Buckley, P ;
Oberley, T ;
Fechner, J ;
Dong, YC ;
Hong, XN ;
Kirk, A ;
Neville, D ;
Knechtle, S .
TRANSPLANTATION, 1998, 66 (01) :5-13
[3]   INDUCTION OF TOLERANCE BY MONOCLONAL-ANTIBODY THERAPY [J].
BENJAMIN, RJ ;
WALDMANN, H .
NATURE, 1986, 320 (6061) :449-451
[4]   ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS [J].
BILLINGHAM, RE ;
BRENT, L ;
MEDAWAR, PB .
NATURE, 1953, 172 (4379) :603-606
[5]   Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease [J].
Bühler, LH ;
Spitzer, TR ;
Sykes, M ;
Sachs, DH ;
Delmonico, FL ;
Tolkoff-Rubin, N ;
Saidman, SL ;
Sackstein, R ;
McAfee, S ;
Dey, B ;
Colby, C ;
Cosimi, AB .
TRANSPLANTATION, 2002, 74 (10) :1405-1409
[6]   The immunological barrier to xenotransplantation [J].
Cascalho, M ;
Platt, JL .
IMMUNITY, 2001, 14 (04) :437-446
[7]  
Cecka J Michael, 2002, Clin Transpl, P1
[8]  
Dai ZH, 1998, J IMMUNOL, V161, P1659
[9]   Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning [J].
Durham, MM ;
Bingaman, AW ;
Adams, AB ;
Ha, JW ;
Waitze, SY ;
Pearson, TC ;
Larsen, CP .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :1-4
[10]   PREVENTION OF COLLAGEN-INDUCED ARTHRITIS WITH AN ANTIBODY TO GP39, THE LIGAND FOR CD40 [J].
DURIE, FH ;
FAVA, RA ;
FOY, TM ;
ARUFFO, A ;
LEDBETTER, JA ;
NOELLE, RJ .
SCIENCE, 1993, 261 (5126) :1328-1330